Incidence of tympanic membrane perforation after intratympanic steroid treatment through myringotomy tubes

18Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Intratympanic (IT) steroids are often used to treat inner ear disorders such as sudden idiopathic sensorineural hearing loss, autoimmune inner ear disease, and Ménière disease. Administration of corticosteroids via IT injection, via application with a pledget to the round window, or via catheter has been used for this purpose. The frequency of adverse events related to the IT injection of steroids is low, with pain, short-lasting vertigo, otitis media, and tympanic perforations being the most common complications. However, the safety of IT steroid therapy has not yet been established in a randomized clinical trial. In this article, we discuss a group of 11 patients with sensorineural hearing loss who underwent myringotomy and tube placement for home-based dexamethasone instillation and subsequently developed the complication of tympanic membrane perforation. It appears that there is a significantly increased incidence of tympanic membrane perforations in this population. © 2011, Vendome Group, LLC. All rights reserved.

Cite

CITATION STYLE

APA

Rutt, A. L., Hawkshaw, M. J., & Sataloff, R. T. (2011). Incidence of tympanic membrane perforation after intratympanic steroid treatment through myringotomy tubes. Ear, Nose and Throat Journal, 90(4). https://doi.org/10.1177/014556131109000416

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free